• Explore /
  • Poster
  • / Circulating tumor DNA (ctDNA) detection of molecular residual disease (MRD) as a potential biomarker in localized soft tissue sarcoma (STS).

Circulating tumor DNA (ctDNA) detection of molecular residual disease (MRD) as a potential biomarker in localized soft tissue sarcoma (STS).

Abstract Poster

Authors

Abdulazeez Salawu

Abdulazeez Salawu

Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON, Canada

Abdulazeez Salawu , Elizabeth Demicco , Peter W. M. Chung , Jordan Feeney , Jasmine Lee , Eoghan Ruadh Malone , Charles Catton , Limore Arones , Madeline J. Phillips , Philip Wong , Jay Wunder , Peter Charles Ferguson , Stephen Willingham , David Benjamin Shultz , Albiruni Ryan Abdul Razak

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Sarcoma

Track

Sarcoma

Sub Track

Molecular Targets/Biomarkers/Tumor Biology

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 11547)

DOI

10.1200/JCO.2022.40.16_suppl.11547

Abstract #

11547

Poster Bd #

451

Abstract Disclosures

Similar Posters

Poster

2023 ASCO Annual Meeting

<span>Dynamic ctDNA to inform the precise management of resected NSCLC: LUNGCA-2 study.</span>

Dynamic ctDNA to inform the precise management of resected NSCLC: LUNGCA-2 study.

First Author: Liang Xia

First Author: Hiroki Yukami

First Author: Yinyin Chang

First Author: De-Zhen Guo